সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

pfizer private limited - azithromycin dihydrate eqv azithromycin - tablet, film coated - 500 mg - azithromycin dihydrate eqv azithromycin 500 mg

সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

pfizer private limited - azithromycin dihydrate eqv azithromycin - tablet, film coated - 600 mg - azithromycin dihydrate eqv azithromycin 600 mg

সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - magnesium chloride; potassium chloride; sodium acetate trihydrate; sodium chloride; sodium gluconate - injection - 30 mg/100 ml - magnesium chloride 30 mg/100 ml; potassium chloride 37 mg/100 ml; sodium acetate trihydrate 368 mg/100 ml; sodium chloride 526 mg/100 ml; sodium gluconate 502 mg/100 ml

মাল্টা - ইংরেজি - Medicines Authority

novartis pharmaceuticals uk limited frimley business park, frimley camberley, surrey gu16 7sr, united kingdom - potassium chloride - tablet - potassium chloride 600 mg - mineral supplements

আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.15 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes

আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium chloride; sodium chloride - solution for infusion - 0.15% w/v + 0.9% w/v percent weight/volume - solutions affecting the electrolyte balance; electrolytes

আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium chloride; sodium chloride - solution for infusion - 0.3% w/v + 0.9% w/v percent weight/volume - solutions affecting the electrolyte balance; electrolytes

ইউরোপীয় ইউনিয়ন - ইংরেজি - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium chloride 750 mg - because of reports of intestinal and gastric ulceration and bleeding with controlled-release potassium chloride preparations, these drugs should be reserved for those patients who cannot tolerate or refuse to take liquid or effervescent potassium preparations or for patients in whom there is a problem of compliance with these preparations. - for the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis. if hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. - for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop e.g., digitalized patients or patients with significant cardiac arrhythmias, hepatic cirrhosis with ascites, states of aldosterone excess with normal renal function, potassium-losing nephropathy, and cer

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

hospira, inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0 - potassium chloride 1.79 g in 1000 ml - these solutions are indicated in patients requiring parenteral administration of potassium chloride and the replacement of extracellular losses of fluids and electrolytes with minimal carbohydrate calories. solutions containing potassium chloride are contraindicated in diseases where high potassium levels may be encountered. solutions containing lactate are not for use in the treatment of lactic acidosis. to open tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication - prepare additive port. prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw need